For instance, the prognostic value of HIF1A in non-small cell lung cancer is altered with EGLN2 expression [21], and gene signature associated with T cell dysfunction can be screened by assessing G × G interactions [22]. This evidence concerns the gene EGLN2 and non-small cell lung carcinoma.